Synvect
Eco-friendly mosquito control powered by CRISPR
La Jolla, United States · Founded 2024 · $3.0M raised
- Headquarters
- La Jolla, California
- Founded
- 2024
- Business Model
- B2B
- Website
- synvect.com
- Total Funding
- $3.0M
- Last Round
- $3.0M SeedMar 2025
- Rounds
- 1
About
Synvect is a CRISPR-based biotechnology company developing an eco-friendly, effective, and evolutionary stable mosquito control platform. Built on 15 years of cutting-edge research and $20M in prior academic funding, the company's next-generation Sterile Insect Technique (ngSIT) technology leverages bioengineered mosquitoes to suppress disease-carrying populations without pesticides or environmental harm. Synvect targets the growing global burden of mosquito-borne diseases such as malaria, dengue, and Zika.
Summary
Synvect is a Healthcare company based in La Jolla, United States, founded in 2024. It has raised $3.0M in total across 1 round, most recently a $3.0M Seed round in Mar 2025. Investors include Bill & Melinda Gates Foundation, Antler and NuFund Venture Group.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2025
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/synvect"><img src="https://indexed.vc/api/badge/company/synvect" alt="Synvect on Indexed.vc" width="260" height="76" /></a>